Introduction
Considering the vast differences in radioactive sources, acceleration methods, standards, and operating procedures between heavy-ion medical accelerators and the commonly used electron beam linear accelerators, there is a need to develop suitable checklists and procedures as the basis for indigenous safety and significance evaluation guidelines for heavy-ion medical accelerators by investigating the usage status of the machine abroad.
As evident in Table 1 
Current Usage Trends of Heavy-ion Medical Accelerator
Like hydrogen ions used in proton accelerators, the carbon ions that are often used in heavy-ion medical accelerators tend to exhibit a Bragg peak, meaning they show a drastic reduction in dose after peaking at the distal end of the beam, with little dose observed at the fore end of the beam, unlike an X-ray beam in which the dose peaks at the surface and subsequently decreases exponentially with increasing depth. 1,2) Such a property allows heavyion accelerators to focus a high dose of radiation on tumor cells in radiotherapy, while reducing radioactive exposures for other healthy organs. In particular, carbon ion exhibits a significantly more pronounced Bragg peak than a hydrogen ion owing to its relative mass, but the tail of the beam is relatively longer than that of a hydrogen ion beam. [3] [4] [5] Most heavy-ion medical accelerators that are currently being operated both domestically and internationally use carbon ion as the radioactive source for treatment, and the energy output of the carbon ion beam is generally set between 400 MeV/u and 430 MeV/u, except for the Heavy Ion Medical Accelerator in Chiba (HIMAC, which produces 800 MeV/u of energy. 6) Unlike proton therapy, all heavyion medical accelerators utilize synchrotron accelerators and a combination of scattering (or passive beam) and scanning (or pencil beam) beam for irradiation. [6] [7] [8] [9] [10] However, it is understood that IBA, which has previously operated cyclotron accelerators, is working in tandem with Russia's JINR to install a heavy-ion accelerator based [24] [25] [26] [27] Thus, it is expected, based on the cancer treatment trends in local proton therapy treatment centers, that the proportion of patients opting for heavy-ion medical accelerator treatment would be significant should it be introduced formally. Furthermore, noting that a radiotherapy for cancer in certain organs such as the lung and the liver may potentially result in undesirable side effects on other healthy organs exposed to low doses of radiation, it is possible to predict that the demand for heavy-ion medical accelerator treatment will increase for lung and liver cancer patients, as studies attesting to the ability of heavy-ion accelerators to focus radiation doses on the tumor target and reduce radioactive exposure to the peripheral organs increase in number. 28, 29) Tables 3 and 4 procedures, and it is recommended that each hospital make amendments to best fit their situation and needs. Steps 2)-3) verify the precision of the zero reference and the ch when the pencil beam is deflected, in which the precision must fa category of the safety dose of the transfer mechanism is meant to the dose transfer mechanism can be maintained steadily. 2) The SOBP conformity and homogeneity category is meant to determine the invariability and homogeneity of SBOP in the longitudinal dose profile, and is validated by taking the SOBP value, defined as the distance between the proximal 90% and the distal 90%, and determining if the value is within 5% of other SOBP values taken randomly.
3)
The Beam Range Adjustment criterion serves to identify if the beam energy modulated by the range modulator and scattering foil falls within ±1 mm of the predicted value.
5. Annual quality control 
Personnel Standards for Safe Operation of Heavy-Ion Medical Accelerators
A team responsible for the maintenance and the safe 
Discussion and Conclusion
Although it is difficult to opt for the introduction of heavy-ion medical treatment equipment due to the relatively expensive installation fee and cost of operation, preparations are being made for its installation in one of the facilities domestically, while a plan to construct another one is under way as well. 32, 37) As such, this study made an investigation into the current trends in the usage of heavy-ion accelerators, compiled 71 keywords relevant to the technology and suggested basic performance index, as well as some quality control criteria and reference values took potential future operation into consideration.
However, it is hoped that the results suggested in this study, while recommended for use as a reference data for hospitals and other facilities planning to introduce heavy-ion accelerators, will be modified by the medical practitioner to formulate an optimum medical system that fits the needs of each facility or hospital. Also, it must be noted that this study does not explain about acceptance trial criteria, procedures and reference standard values, nor does it discuss any beam data criteria for treatment plan, procedures, acceptance trial and regular quality control of treatment plan that should be taken into consideration for choosing and efficient operation of a suitable radiation therapy treatment plan. Hence, a comprehensive guideline for radiation therapy treatment system based on heavyion medical accelerator technology must be completed after sufficient research on the acceptance trial and quality control of treatment plans for the medical equipment has been carried out. Also, for safe and efficient clinical operation of an enormous and complex system like a heavy-ion based medical equipment, sufficient number of medical practitioners must be secured, which would help to ameliorate the overall quality of patient treatment.
